Sieben, Nathalie L G <br/><br/>
In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.  [electronic resource] 

 -  The Journal of pathology  Mar 2004 
 - 336-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-3417 
<br/><br/><label>Standard No.: </label>10.1002/path.1521  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cystadenoma, Mucinous--genetics<br/>Cystadenoma, Papillary--genetics<br/>Cystadenoma, Serous--genetics<br/>Female<br/>Humans<br/>Mutation<br/>Ovarian Neoplasms--genetics<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins B-raf<br/>Proto-Oncogene Proteins c-raf--genetics<br/>Proto-Oncogene Proteins p21(ras)<br/>ras Proteins